Point72 Asset Management Boosts Broadcom, Meta Platforms, Uber Technologies, Amazon, Transdigm Group, Fidelity, Dominion Energy

Mesoblast Limited (NASDAQ:MESO, ASX:MSB))), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that funds managed by Oaktree Capital Management, L.P. ("Oaktree") have extended to Mesoblast the availability of up to an additional US$30.0 million of its US$90 million five year facility subject to achieving certain milestones on or before September 30, 2023.